CELESTI FABRIZIO

Fabrizio
Celesti
Ricercatore Legge 240/10 - tempo determinato

Attività di ricerca

Ultime pubblicazioni:

  • Celesti, F., Fazio, M., Celesti, A. (2026). Deep Learning in Multiomics Sciences: Where We are, Emerging Topics, and Future Challenges. In IEEE Symposium on Computers and Communications ISCC (pp.1-6) [10.1109/iscc65549.2025.11326486]. - dettaglio
  • Lonia, G., Ciraolo, D., Bonanno, M., Calabrò, R.S., Celesti, F., Fazio, M., et al. (2025). Data Fusion in Tele-Rehabilitation: Combining Cognitive and Motor Datasets to Train a Machine Learning Model for Assessing Patients' Outcomes. In 2025 IEEE Medical Measurements & Applications (MeMeA) (pp.1-6). Institute of Electrical and Electronics Engineers Inc. [10.1109/memea65319.2025.11068077]. - dettaglio
  • Lofiego, M.F., Tufano, R., Bello, E., Solmonese, L., Marzani, F., Piazzini, F., et al. (2025). Abstract 4841: DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy. In Cancer Research (pp.4841-4841) [10.1158/1538-7445.am2025-4841]. - dettaglio
  • Lofiego, M.F., Tufano, R., Bello, E., Solmonese, L., Marzani, F., Piazzini, F., et al. (2025). DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 44(1) [10.1186/s13046-025-03310-0]. - dettaglio
  • Solmonese, L., Lofiego, M.F., Fazio, C., Marzani, F., Piazzini, F., Bello, E., et al. (2025). The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets. ONCOTARGETS AND THERAPY, 18, 995-1012 [10.2147/OTT.S527785]. - dettaglio